EUVIMEDEUVIMED entdecken
StudienprotokollOpen Access · CC BY 4.0

India Hypertension Control Initiative: Blood Pressure Control Using Drug and Dose-Specific Standard Treatment Protocol at Scale in Punjab and Maharashtra, India, 2022

Prabhdeep Kaur iD, Manikandanesan Sakthivel, Vettrichelvan Venkatasamy iD, Padmaja Jogewar, Sandeep S Gill, Abhishek Kunwar, Meenakshi Sharma, Anupam Khungar Pathni iD, Kiran Durgad, Swagata Kumar Sahoo, Amol Wankhede, Navneet Kumar und 11 weitere

Global Heart · 19.03.2024 · 19 (1) · 30

DOI: 10.5334/gh.1305 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Global Heart, online erschienen am 19.03.2024. Verfasst von Prabhdeep Kaur und 22 weiteren Autor:innen. Beteiligte Einrichtung: ICMR - National Institute of Epidemiology Author Institution is Unverified Chennai, IN. Hauptthemen laut MEDLINE: Hypertension. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertension treatment coverage is low in India. A stepwise simple treatment protocol is one of the strategies to improve hypertension treatment in primary care. We estimated the effectiveness of various protocol steps to achieve blood pressure (BP) control in public sector health facilities in Punjab and Maharashtra, India, where the India Hypertension Control Initiative (IHCI) was implemented.

Methods

We analyzed the records of people enrolled for hypertension treatment and follow-up under IHCI between January 2018 and December 2021 in public sector primary and secondary care facilities across 23 districts from two states. Each state followed a different treatment protocol. We calculated the proportion with controlled BP at each step of the protocol. We also estimated the mean decline in BP pre- and post-treatment.

Results

Of 281,209 patients initiated on amlodipine 5 mg, 159,292 continued on protocol drugs and came for a follow-up visit during the first quarter of 2022. Of 33,450 individuals who came for the follow-up in Punjab and 125,842 in Maharashtra, 70% and 76% had controlled BP, respectively, at the first step with amlodipine 5 mg. In Punjab, at the second step with amlodipine 10 mg, the cumulative BP control increased to 75%. A similar 5% (76%–81%) increase was seen in the second step after adding telmisartan 40 mg in Maharashtra. Overall, the mean (SD) systolic blood pressure (SBP) decreased by 16 mmHg from 148 (15) mmHg at the baseline in Punjab. In Maharashtra, the decline in the mean (SD) SBP was about 15 mmHg from the 144 (18) mmHg baseline.

Conclusion

Simple drug- and dose-specific protocols helped achieve a high control rate among patients retained in care under program conditions. We recommend treatment protocols starting with a single low-cost drug and escalating with the same or another antihypertensive drug depending on the cost and availability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionHumansBlood PressureIndiaAntihypertensive AgentsAmlodipineClinical ProtocolsTreatment Outcome

Stichwörter der Autor:innen

Antihypertensive AgentsBlood PressureClinical ProtocolsHypertensionIndiaNational Health ProgramsTreatment Outcome

Substanzen

Antihypertensive AgentsAmlodipine

Autor:innen und Institutionen

  • ICMR - National Institute of Epidemiology Author Institution is Unverified Chennai, IN.
  • Division of Noncommunicable Diseases, ICMR-National Institute of Epidemiology, Chennai, IN.
  • IHCI project, ICMR-National Institute of Epidemiology, Chennai, IN.
  • State NCD Cell, Directorate of Health and Family Welfare, Government of Maharashtra, Mumbai, IN.
  • State NCD Cell, Directorate of Health and Family Welfare, Government of Punjab, Chandigarh, IN.
  • Division of Noncommunicable Diseases, WHO Country Office for India, New Delhi, IN.

ORCID-Profile: Prabhdeep Kaur, Vettrichelvan Venkatasamy, Anupam Khungar Pathni, Tejpalsinh Chavan, Parasuraman Ganeshkumar

Förderung

  • World Health Organization

Zitieren

APA

Kaur, P., Sakthivel, M., Venkatasamy, V., Jogewar, P., Gill, S. S., Kunwar, A., Sharma, M., Pathni, A. K., Durgad, K., Sahoo, S. K., Wankhede, A., Kumar, N., Bharadwaj, V., Das, B., Chavan, T., Khedkar, S., Sarode, L., Bangar, S. D., Krishna, A., …, & Bhargava, B. (2024). India Hypertension Control Initiative: Blood Pressure Control Using Drug and Dose-Specific Standard Treatment Protocol at Scale in Punjab and Maharashtra, India, 2022. Global Heart, 19(1), 30. https://doi.org/10.5334/gh.1305

Vancouver

Kaur P, Sakthivel M, Venkatasamy V, Jogewar P, Gill SS, Kunwar A, et al. India Hypertension Control Initiative: Blood Pressure Control Using Drug and Dose-Specific Standard Treatment Protocol at Scale in Punjab and Maharashtra, India, 2022. Global Heart. 2024;19(1):30. doi:10.5334/gh.1305

BibTeX
@article{Kaur2024,
  author = {Kaur, Prabhdeep and Sakthivel, Manikandanesan and Venkatasamy, Vettrichelvan and Jogewar, Padmaja and Gill, Sandeep S and Kunwar, Abhishek and Sharma, Meenakshi and Pathni, Anupam Khungar and Durgad, Kiran and Sahoo, Swagata Kumar and Wankhede, Amol and Kumar, Navneet and Bharadwaj, Vishwajit and Das, Bidisha and Chavan, Tejpalsinh and Khedkar, Suhas and Sarode, Lalit and Bangar, Sampada D and Krishna, Ashish and Shivashankar, Roopa and Ganeshkumar, Parasuraman and Pragya, Pragati and Bhargava, Balram},
  title = {India Hypertension Control Initiative: Blood Pressure Control Using Drug and Dose-Specific Standard Treatment Protocol at Scale in Punjab and Maharashtra, India, 2022},
  journal = {Global Heart},
  year = {2024},
  volume = {19},
  number = {1},
  pages = {30},
  doi = {10.5334/gh.1305}
}
Kostenlos starten →